Levetiracetam Pensa

Levetiracetam, the active ingredient in Levetiracetam Pensa, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of various seizure types in patients with epilepsy, including partial‑onset, generalized tonic‑clonic and myoclonic seizures, and is prescribed by neurologists worldwide.

GNH USA supplies Levetiracetam Pensa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from dedicated technical support and regulatory expertise.

Levetiracetam is an anticonvulsant that targets neuronal excitability in epilepsy.

- Partial-onset seizures: reduces frequency of focal seizures in patients with epilepsy. - Generalized tonic-clonic seizures: helps control convulsive episodes across the brain. - Myoclonic seizures: diminishes rapid muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Fatigue - Somnolence - Headache

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts or behavior

When prescribing Levetiracetam, clinicians should consider several safety aspects.

- Renal impairment: adjust dose as recommended by prescriber. - Hepatic impairment: monitor liver function during therapy. - Pregnancy: discuss potential risks with prescriber due to limited data. - Concomitant CNS depressants: monitor for increased sedation. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenobarbital: may reduce levetiracetam levels. - Phenytoin: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Other antiepileptic drugs: may require dose adjustments based on clinical response.